The Marlborough region of New Zealand’s South Island is home to a world-famous Sauvignon Blanc industry. The unique topography creates richly fertile lands, complemented by a cool sea breeze from the rolling tides of the South Pacific. Growing among the vineyards, a new industry is emerging — medical cannabis.
Founded in 2018, Puro is the country’s largest licensed medical cannabis cultivator. Within the first two years of commercial operation, Puro established two cultivation sites in Marlborough and is growing medical cannabis at both locations — even when faced with delays and difficulties caused by the pandemic.
What really sets Puro apart from other commercial growers, both domestically and internationally, is the fact they are growing medical cannabis with organic protocols and working towards being certified organic.
“Once we achieve organic accreditation, we anticipate Puro will be the largest organic grower in Australasia and one of a very small number of organic medical cannabis cultivators worldwide,” said Managing Director Tim Aldridge. “This is going to provide Puro with a highly marketable point of difference.”
Puro’s indoor research facility grows high THC genetics, and the outdoor coastal farm in Kēkerengū grows low THC, high CBD, and CBG cultivars. The farm sees an average of 2,457 hours of sunshine per year, with a high UV rating — optimal conditions for cultivating exceptional outdoor cannabis.
“Kēkerengū provides perfect growing conditions, with a coastal microclimate that is ideal for medical cannabis production,” Aldridge said.
In December 2020, the first ten hectares of plants went into the ground at Kēkerengū. Aldridge and his cultivation team are eagerly awaiting the imminent first harvest, believing the farm’s unique terroir could produce some novel terpene and cannabinoid profiles.
Additionally, Puro’s drying facility is the largest of its kind in New Zealand. It houses the company’s drying and trimming machinery, which is being put to work during the first commercial harvest, which officially started on March 24th and is expected to last through April.
Working Towards Organic Certification
Puro is working hard to set new global standards in organic cannabis cultivation as they move closer towards obtaining organic certification with BioGro.
Growing cannabis under strict organic protocols requires the skill and determination of an internationally experienced agronomy team.
Cultivation Director and Churchill Fellow, Tom Forrest, is Puro’s cannabis cultivation specialist. His intimate knowledge and understanding of controlled pharmaceutical growing operations have been instrumental in developing Puro’s sustainable, organic and regenerative approach to growing.
“Sustainability is essential for the future of agronomy, but [it] also works to produce healthier, happier and more lucrative crops,” Forrest said.
Forrest and his cultivation team are committed to creating a healthy rhizosphere to encourage stronger, more vigorous crops.
“Although the evidence is still anecdotal, we are confident that biological, natural, organic cultivation methods will encourage healthier growth that will result in higher concentrations of terpenes, flavonoids and cannabinoids,” Forrest said.
Having a diverse soil environment is especially ideal for Puro’s six different cultivars: two auto-flowering CBD dominant varietals, two CBG dominant varietals, and two CBD dominant varietals – all sourced from leading global breeders.
“The genetics were selected in response to the evolving worldwide cannabis market and the unpredictable nature of broad-acre cultivation,” Forrest explained.
Protecting local biodiversity is a big part of Puro’s sustainability mandate, and according to Forrest, the company is “firmly focused on improving and refining our sustainability performance from season to season to be a true leader in this space.”
Expansion Goals
In its first round of investment in 2019, Puro raised $4 million on PledgeMe — the highest amount raised on the crowdfunding platform. Puro is now working to finance further developments, including the completion of its indoor breeding facility and the development of its first glasshouse in Waihopai.
These facilities will sit beside Puro’s existing research center and play an important role in continuously improving its crop genetics. At the time of writing, Puro had reached half of the $2 million investment goal.
The company is also working with New Zealand Trade and Enterprise (NZTE) to facilitate the country’s first-ever export of bulk medical cannabis. One contract is already in in place with a local buyer, and Puro is in further negotiations with other potential buyers.
As more countries around the world continue to work towards legalization, sustainability is a big part of the conversation.
Aldridge says operating with sustainable business practices is the right thing to do for the environment, the community and their collective future.
“Sustainability is a core aspect of Puro’s ethos,” Aldridge reiterated. “Our sustainable focus will also ensure Puro is here for the long-term, as we are taking responsibility to enhance and regenerate the land that nurtures our plants now and into the future.”
Speakeasy Dispensary plans to open its Maysville medical cannabis store at 11 a.m. Eastern on Thursday, November 5, at 317 W. Second Street. The opening gives eligible patients in Mason County another place to plan a dispensary visit. For residents who are still applying for a Kentucky medical cannabis card, the company has also listed a patient drive at the same address.
The company announced the opening November 3. The Mason County Post previously reported that the storefront was coming to downtown Maysville near Caproni’s on the River. Patients traveling specifically for the launch should check with the store before leaving, especially if they need to arrange a ride or coordinate with a caregiver.
Two reasons to visit the same address
Speakeasy’s event calendar lists the Maysville patient drive from 11 a.m. to 5 p.m. on November 5. Those hours describe the event. Anyone planning to shop later in the week should check the store’s regular hours separately. If the purpose of the trip is to learn how to apply, check the event listing for registration details and ask the organizer what paperwork to bring.
The distinction matters because a patient drive and a dispensary purchase happen at different points in the process. Kentucky’s patient and caregiver FAQ directs prospective Kentucky patients to an authorized practitioner for written certification and to the state for the registry identification card application. A prospective patient can use the drive to ask about those steps. Someone who already has an active card can focus on store hours, what identification the retailer requests and whether the relevant product is available.
For households coordinating care, the state has a separate designated caregiver process. The patient must designate the caregiver through the registry application process, and the caregiver must also apply and receive approval. Kentucky says a designated caregiver may buy medical cannabis for the registered patients they have been approved to assist. That makes it useful to confirm whose registry credentials are current before deciding who will make the trip.
What a closer storefront changes
A local dispensary can make a recurring errand easier to coordinate. The practical gain is especially clear if a patient has to work around someone else’s availability or combine the visit with other stops. But the address alone tells readers little about the time a particular visit will take, the cost of a purchase or the menu on opening day. The announcement establishes the location and planned opening, so call the retailer for those other details before treating a trip as settled.
The distinction between a license and an operating storefront came up in our October coverage of Kentucky’s dispensary rollout. That statewide story used the state directory to distinguish retail locations patients could visit from businesses still working toward operation. Maysville gives readers a specific address and opening date to follow. A new statewide count would require checking the current directory, including changes elsewhere in the state since that earlier report.
Check the rules before crossing the river
Maysville’s location on the Ohio River adds another question for readers coming from outside Kentucky. The state describes a visiting qualified patient pathway with eligibility conditions, including a valid out-of-state registry card and documentation of a qualifying diagnosis. Check the Kentucky program’s current patient guidance and ask the store what documentation it needs before traveling. Permission to purchase in Kentucky and the rules that apply when traveling with cannabis are separate questions. A dispensary visit should not be treated as permission to take a purchase across a state line.
Check product rules as well as purchase eligibility. Kentucky lists forms such as oils, edibles and raw plant material among products its medical program allows, subject to program rules. The state prohibits smoking the raw plant material. Seeing flower on a menu therefore does not tell a patient how it may be used. For a first visit, the most useful questions are concrete: whether the store is open, whether the patient or caregiver has the required documents, and whether the intended product is available. For someone just getting started, the patient drive offers a separate opportunity to ask how to enter the program.
For patients comparing locations, Kentucky’s program resources are a useful place to start before checking an individual store. Keep the clinic visit, application and dispensary trip separate when planning time and transportation. A person attending the drive for information may have no reason to arrange a second trip until they know what the state requires and where they are in the application process.
Cannabis Shoppers Expect Tax Savings to Reach the Shelf. Will They?
A NuggMD survey reported this week finds that 74 percent expect cannabis companies to pass on tax savings. The result measures consumer expectations, not an observed price cut.
Cannabis consumers are looking for a share of the savings if federal tax relief improves operators’ finances. A NuggMD poll reported November 3 found that 74 percent of respondents expect companies to pass along savings through lower prices if rescheduling brings tax relief. The result captures a clear consumer expectation. It does not establish that prices have fallen or that every cannabis business receives the same relief.
Marijuana Moment’s Tom Angell reported the findings from 654 consumers in state-legal markets surveyed October 8–15. The reported margin of error was approximately 3.83 percentage points. Twenty-six percent expected companies to retain the savings while keeping prices at their current level.
What the survey can tell us
The question was conditional: it asked what consumers expected if companies received rescheduling-related tax relief. That wording is important. Respondents were not reporting a verified reduction in a particular operator’s tax bill, and they were not comparing receipts before and after a change in federal policy.
The sample also consisted of cannabis consumers in legal markets, rather than all American adults. Its findings should be described within that population. The publicly reported summary provides useful dates, sample size and question wording, but does not establish that every state, product category or type of consumer shares the same view.
For operators, the finding is a communication challenge as much as a pricing question. Customers may hear a headline about lower taxes and reasonably ask what it changes for them. A clear answer needs to separate the business’s actual eligibility, the timing of any benefit and the decisions it makes about retail prices.
Why Section 280E matters
Section 280E is the federal tax provision at the center of the discussion. In its April 23 announcement, Treasury and the IRS explained that the provision generally denies deductions and credits for businesses trafficking in Schedule I or II controlled substances in violation of federal or state law.
The agencies said the medical-marijuana rescheduling order generally removes that barrier for activities that, because of the order, no longer involve Schedule I or II substances. They also described planned guidance for businesses conducting multiple activities, including how expenses might be apportioned. That is a more qualified proposition than saying the tax restriction has disappeared for every cannabis sale.
Treasury’s statement anticipated a transition rule related to the taxable year containing the order’s effective date. The announcement describes expected guidance; it should not be treated as a substitute for checking the rules and advice applicable to a particular business. This article is about the consumer implications of the policy debate, rather than instructions for preparing a return.
Tax treatment is not a shelf-price rule
The IRS’s cannabis industry guidance continues to distinguish tax responsibilities from the legality of the underlying activity. Income remains reportable, and businesses must keep records and meet applicable payment and information-reporting requirements. Relief from a specific restriction does not remove the rest of the tax system.
There is also a basic distinction between lowering taxable income through a deduction and reducing a product’s price by the same dollar amount. A deduction affects how a business calculates its tax obligation. A retail price is what that business charges for a particular product. The two can be connected through business decisions without being mechanically identical.
The relevant question for a consumer is therefore more specific than whether a store sells cannabis. It is which activities qualify for the changed treatment, when that treatment applies and how the operator explains any resulting benefit.
That leaves several possibilities for any operator benefiting from relief: lower prices, investment in the business, improved financial resilience or some combination. The poll does not identify what companies will choose, and it would be premature to promise customers a uniform discount. Equally, an operator should not present a possible tax improvement as evidence that its shoppers have already benefited.
What consumers can actually compare
The clearest evidence for a customer is the price of a comparable purchase over time. Comparing the same product size and formulation, and distinguishing the base price from taxes or a temporary promotion, is more informative than treating a general rescheduling headline as a receipt.
Our coverage of medical cannabis registrations explains another part of the changing federal framework. Registration, tax treatment and retail pricing are related developments, but each requires its own evidence.
The survey’s immediate message is therefore straightforward: many cannabis shoppers expect a benefit they can see. Whether that expectation is met will be demonstrated by actual pricing and company disclosures, rather than by a poll result or a promised future guidance document alone.
Illustrative stock budgeting photograph; not a cannabis customer or company account. Photo: Kaboompics / Pexels.
Houston’s Cannabis Enforcement Vote Now Turns to Implementation
Houston’s approved charter change focuses on police priorities, diversion and public accounting. It does not create a legal cannabis market or guarantee that possession cannot lead to enforcement.
Houston voters have approved a charter amendment directing city police to give Class A and Class B misdemeanor marijuana possession their lowest enforcement priority. The cannabis provision sits alongside a ban on no-knock warrants in Proposition A, also called the Houston Freedom Act. The next part of the story is how the city translates those instructions into budgets, police policies, training and public reports.
The text directs the Houston Police Department to make the specified misdemeanor possession offenses its lowest possible enforcement priority unless a binding state or federal court action requires otherwise. It calls for corresponding changes to the annual budget, department manual and relevant procedures. That links the policy to how the city allocates work and resources, not just to a statement of preference.
The charter language also preserves limits that matter to residents. An officer who has probable cause to believe a substance is marijuana may seize it and must explain the grounds in a report. The diversion section preserves law-enforcement and prosecutorial discretion to enforce state law. A lower-priority directive therefore should not be described as a guarantee against a police encounter, seizure or prosecution.
Nor does a city enforcement measure establish a state-licensed adult-use market. It does not create retail licenses or set up a new system for purchasing cannabis. Those are different legal questions from how municipal personnel prioritize a category of existing offenses. The practical distinction is essential for anyone reading the outcome as permission to possess or sell marijuana.
Diversion is part of the design
The measure supports diversion where legally permissible for people accused of the covered offenses. Examples in the text include mental-health or substance-use treatment referrals, community service and other alternatives to arrest or prosecution consistent with the cited Texas criminal-procedure provision.
That language describes a policy direction with legal qualifications. It does not promise that every individual will receive the same referral or qualify for the same alternative. Implementation will need to show what options are actually available and how decisions are made. An announcement that a measure passed cannot answer those case-specific questions.
The campaign organization Ground Game Texas promoted the Houston Freedom Act as an effort to redirect police resources and change marijuana enforcement. Its support explains the initiative’s advocacy context. The adopted language, subsequent city policies and actual enforcement records will be more useful for assessing results than campaign expectations alone.
The accounting provisions deserve attention
The city’s published text requires a one-time review of misdemeanor marijuana enforcement during the preceding five years. The audit is to include arrests, citations and demographic information, alongside estimates of staff hours, per-charge costs and spending on THC testing and enforcement. It is intended to be presented at a public council meeting and made available online.
The annual reporting requirement adds another way to follow implementation. The text calls for information including arrests, citations, diversion referrals, demographic breakdowns and estimated staff hours. This creates a framework for asking whether the new priority is reflected in practice. A report’s existence would not establish success on its own; the contents and their consistency over time will matter.
The THC-testing provisions similarly seek visibility into spending and staff time. That is a different question from whether testing can ever occur. The charter text contemplates council funding for testing when a compelling public-safety purpose is identified. Readers should avoid turning a budget-transparency provision into a claim that the city has prohibited every test.
What to watch after the vote
The no-knock provision is a separate substantive part of the same amendment. It bars Houston officers from requesting or executing warrants that do not require announcement and a wait of at least 15 seconds before entry. Its inclusion helps explain why Proposition A cannot be reduced to a cannabis-only retail or possession proposal.
For cannabis readers, the useful next milestones are official election certification, implementation instructions and the required public accounting. Those will show how the city applies a lower-priority policy while operating within the legal limits stated in the measure.
Our Idaho ballot coverage concerned who could change cannabis law. Houston’s vote concerns municipal enforcement priorities. Both involve voter participation, but their effects should be judged on the specific language voters approved rather than treated as interchangeable forms of legalization.
Illustrative stock view of Houston; not election-night photography. Photo: Eddie O. / Pexels.